Suxibuzone
CAS: 27470-51-5
Ref. 3D-FS30707
25mg | Descatalogado | ||
50mg | Descatalogado | ||
100mg | Descatalogado | ||
250mg | Descatalogado | ||
500mg | Descatalogado |
Información del producto
- 3,5-Pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester)
- 4-Hydroxymethylbutazolidine hemisuccinate
- 4-[(4-Butyl-3,5-Dioxo-1,2-Diphenylpyrazolidin-4-Yl)Methoxy]-4-Oxobutanoic Acid
- Ae 17
- Butanedioic acid, 1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
- Butanedioic acid, mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester
- Calibene
- Danilon
- Flogos
- Solurol
- Ver más sinónimos
- Succinic acid, monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione
- Suxibutazone
Suxibuzone is a nonsteroidal anti-inflammatory drug that has been shown to be effective in the treatment of inflammatory skin diseases and autoimmune diseases. Suxibuzone has also been used as an anti-infective agent against microbial infections, such as Helicobacter pylori. Suxibuzone is a biocompatible polymer that can be used for blood sampling and sample preparation. It can be synthesized in analytical methods and it may have therapeutic applications for skin cancer and choroidal neovascularization. Suxibuzone is also capable of delivering drugs to liver cells via nanoparticulate compositions.